MX9102757A - Vacuna de virus de enfermedad de marek sin celulas. - Google Patents

Vacuna de virus de enfermedad de marek sin celulas.

Info

Publication number
MX9102757A
MX9102757A MX9102757A MX9102757A MX9102757A MX 9102757 A MX9102757 A MX 9102757A MX 9102757 A MX9102757 A MX 9102757A MX 9102757 A MX9102757 A MX 9102757A MX 9102757 A MX9102757 A MX 9102757A
Authority
MX
Mexico
Prior art keywords
vaccine
marek
disease virus
cells
disease
Prior art date
Application number
MX9102757A
Other languages
English (en)
Inventor
William Baxendale
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9102757(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of MX9102757A publication Critical patent/MX9102757A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16361—Methods of inactivation or attenuation
    • C12N2710/16364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX9102757A 1990-12-24 1991-12-23 Vacuna de virus de enfermedad de marek sin celulas. MX9102757A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90314297 1990-12-24

Publications (1)

Publication Number Publication Date
MX9102757A true MX9102757A (es) 1992-07-01

Family

ID=8205666

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102757A MX9102757A (es) 1990-12-24 1991-12-23 Vacuna de virus de enfermedad de marek sin celulas.

Country Status (17)

Country Link
US (1) US5378467A (es)
EP (1) EP0496135B1 (es)
JP (1) JP3410744B2 (es)
KR (1) KR100187317B1 (es)
CN (1) CN1034554C (es)
AT (1) ATE109007T1 (es)
CA (1) CA2058386C (es)
DE (1) DE69103130T2 (es)
DK (1) DK0496135T3 (es)
DZ (1) DZ1550A1 (es)
ES (1) ES2061165T3 (es)
HU (2) HUT62200A (es)
IL (1) IL100386A (es)
MX (1) MX9102757A (es)
NZ (1) NZ241122A (es)
SA (1) SA92120430B1 (es)
ZA (1) ZA9110022B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
US5565202A (en) * 1994-08-12 1996-10-15 The United States Of America As Represented By The Secretary Of Agriculture Low enhancement serotype 2 vaccine for marek's disease
FR2857671B1 (fr) 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
EP2384761B1 (en) 2010-05-07 2013-09-04 Deutsches Krebsforschungszentrum Modified rodent parvovirus capable of propagating and spreading through human gliomas
BR112020012162A2 (pt) 2017-12-20 2020-11-24 Intervet International B.V. diluente aprimorado para vacina contra alfa-herpesvírus associado à célula

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4895718A (en) * 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法

Also Published As

Publication number Publication date
JP3410744B2 (ja) 2003-05-26
SA92120430B1 (ar) 2004-05-31
CN1034554C (zh) 1997-04-16
DE69103130D1 (de) 1994-09-01
HUT62200A (en) 1993-04-28
CA2058386C (en) 2003-02-11
HU914111D0 (en) 1992-03-30
DE69103130T2 (de) 1994-12-01
KR100187317B1 (ko) 1999-05-01
EP0496135A2 (en) 1992-07-29
CN1064409A (zh) 1992-09-16
ES2061165T3 (es) 1994-12-01
JPH04295433A (ja) 1992-10-20
ZA9110022B (en) 1992-10-28
DK0496135T3 (da) 1994-11-28
IL100386A (en) 1995-07-31
KR920011520A (ko) 1992-07-24
EP0496135A3 (en) 1992-08-05
IL100386A0 (en) 1992-09-06
NZ241122A (en) 1992-10-28
HU210344A9 (en) 1995-04-28
DZ1550A1 (fr) 2002-02-17
EP0496135B1 (en) 1994-07-27
CA2058386A1 (en) 1992-06-25
ATE109007T1 (de) 1994-08-15
US5378467A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
BR9102672A (pt) Composicao para exterminar microorganismos, composicao para exterminar virus envelopados, processo para exterminar microorganismos em ou sobre um hospedeiro e processo para exterminar virus envelopados em um ser humano ou animal de sangue quente, hospedeiro
CA2121241A1 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
ES2061500T5 (es) Diagnosis y vacunas de la hepatitis delta, su preparacion y uso.
BR9202024A (pt) Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo
MY103575A (en) Cannie coronavirus vaccine
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
DE3071594D1 (en) Feline infectious peritonitis virus, its preparation and vaccines containing it
IE780360L (en) Vaccine against "egg drop disease".
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
CA2116355A1 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
FI890116A (fi) Icke-reverterande rna-virus.
DK1087014T3 (da) Svinepestvirusvaccine og -diagnostik
MX9602256A (es) Vacuna contra la enfermedad de marek.
ES515472A0 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
Loebenstein et al. Plant defense responses to viral infections.
ATE3058T1 (de) Herpes-virus-impfstoff und seine herstellung.
TH12563EX (th) วีคซีนป้องกันไวรัสโรคมาเร็คชนิดปราศจากเซลล์
Wargo Interaction of stress and secondary organisms in decline of forest trees.
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
Von Ohlinger et al. Boar vaccination against Aujeszky's disease. 2. Communication: Virus excretion in nasal secretions and semen.
EP0244760A3 (en) Vaccine for the prevention of marek's disease
Joklik Antigenic relationships between the proteins of the three serotypes of reovirus.
ES2084587T3 (es) Arn virus no revertientes.
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.